Mycotoxin vs Spore Homeowner Education Script

Why this matters

Homeowners arrive at the first consultation having read about "toxic black mold," "mycotoxin poisoning," "MARCoNS," "biotoxin illness," and a dozen other terms that mix legitimate science with alternative-medicine marketing. The contractor's job is not to validate every claim and not to dismiss every fear. The job is to set a defensible scope based on what mold remediation actually addresses, and to make clear what falls outside the remediation contractor's lane. This reference is the script structure that lets a senior estimator have a 20-minute consultation that ends with an aligned scope, no inflated promises, and no antagonism toward the customer's online research.

The two-track framing

Open the conversation with a two-track distinction:

There are two separate questions here. One is "is there a moisture problem and visible mold growth in the building, and what does it take to remove it and prevent recurrence." That is what I do, and I can answer that today. The second is "is anyone in the house sick from mold exposure, and what should they do about it." That is a medical question, and I am not the right person for it. The right person is a physician with environmental-medicine training. We can talk about both, but I want to be honest with you up front about which side of the line I sit on.

That paragraph buys you trust. It tells the homeowner you are not going to oversell and not going to dismiss. It also legally separates your remediation scope from the medical claim, which matters when the homeowner later asks "did your work cure my symptoms."

Spores

Spores are the reproductive cells of mold. They are airborne, they settle on surfaces, they are the thing measured by spore-trap clearance sampling.

The plain-language explanation:

When mold grows on a wet surface, it makes spores, the same way a dandelion makes seeds. Spores float in the air, settle on dust, and if they land on another wet surface they start a new colony. Killing a spore does not make it disappear; a dead spore still floats and still settles. That is why our work is about physically removing contaminated material and capturing the spores in HEPA filters, not just spraying chemicals.

Spores are what regulated mold-remediation work targets. Spore counts are what clearance sampling measures. Spore exposure causes the well-documented allergic responses (sneezing, runny nose, asthma exacerbation) and, in immune-compromised individuals, opportunistic infections.

Mycotoxins

Mycotoxins are secondary metabolites produced by some mold genera under certain growth conditions. Stachybotrys chartarum, several Aspergillus species, Penicillium, Fusarium, and others can produce mycotoxins. The molecules are real; the indoor-air exposure pathway and dose-response are scientifically contested.

The plain-language explanation:

Some molds, under some conditions, produce chemicals called mycotoxins. These chemicals are real and well-studied in agriculture, where contaminated grain feed has killed livestock for decades. Where the science gets less settled is whether the levels of these chemicals in air or settled dust inside a typical contaminated home are high enough to cause illness in people. Mainstream public-health agencies including CDC and the World Health Organization have stated that the evidence for indoor-air mycotoxin illness is limited. There is a separate clinical community that disagrees. I am not going to take a side on the medicine. What I will tell you is that whether you believe the higher-end claims or the more conservative claims, the action item is the same: remove the source, remove the contaminated material, clean the building. That is what I do.

That paragraph respects both communities and refuses to be drawn into a medical opinion. It also points out that the remediation work product is identical regardless of which medical view turns out to be correct, which is the strongest sales position.

What the contractor will not test for

Many homeowners will ask for mycotoxin testing of their dust or air. Hold a clear line:

Mycotoxin testing of indoor dust is offered by several commercial labs. The results are difficult to interpret because there is no agreed-upon "safe" threshold and the relationship between dust mycotoxin levels and air exposure is not established. I will not bill that test as part of my remediation scope, because passing or failing a mycotoxin dust test does not change what the remediation needs to do. If you want to pursue that testing on your own, I can refer you to a lab, and we can read the results together, but I am not going to base our scope or our clearance on it.

That answer is the legally defensible one. Basing remediation scope on a metric for which there is no consensus pass/fail criterion creates an open-ended liability.

MARCoNS, CIRS, and biotoxin-illness terminology

If a homeowner arrives using terms such as MARCoNS (multi-antibiotic-resistant coagulase-negative Staphylococci), CIRS (chronic inflammatory response syndrome), or "Shoemaker protocol," they have been working with a physician who follows a specific clinical framework. The contractor's response is:

Those are clinical terms used by some physicians, and they are part of a specific treatment approach. I do not practice medicine and I am not going to comment on the framework. What I can tell you is that physicians who work with this framework typically refer patients to remediation contractors who follow established standards such as IICRC S520, and that is what I do. If your doctor has a specific written protocol they want me to follow that differs from S520, send it over and I will tell you what is reasonable and what is outside my license.

Some physicians write a remediation protocol so specific (HEPA-vacuuming with a specific brand, encapsulation with a specific product, ERMI testing) that the contractor is asked to deviate from S520. Read the protocol, accept the deviations that are not unreasonable, decline the ones that are (such as ozone in an occupied home), and document the decision in writing.

ERMI and HERTSMI-2

References

• IICRC S520 Standard for Professional Mold Remediation, 4th Edition (2024), Section 4 (Principles of Mold Remediation) and Section 16 (Post-Remediation Evaluation).
• CDC "Mold" topic page and "Facts about Stachybotrys chartarum," position that adverse health effects from inhaled mycotoxins in non-occupational indoor settings have not been proven.
• World Health Organization Guidelines for Indoor Air Quality: Dampness and Mould (2009), conclusion that exposure should be minimized but mycotoxin causation in residential settings is limited.
• EPA Indoor Air Quality "Mold Course" and the EPA statement that ERMI is "a research tool" not validated for individual building decisions.
• Institute of Medicine "Damp Indoor Spaces and Health" (2004), the consensus literature review most often cited in mold-litigation expert testimony.